Logo image of CJMB

CALLAN JMB INC (CJMB) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CJMB - US1311001093 - Common Stock

2.6 USD
+0.1 (+4%)
Last: 12/1/2025, 1:30:01 PM
Fundamental Rating

2

Overall CJMB gets a fundamental rating of 2 out of 10. We evaluated CJMB against 23 industry peers in the Air Freight & Logistics industry. While CJMB has a great health rating, there are worries on its profitability. CJMB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CJMB had negative earnings in the past year.
In the past year CJMB has reported a negative cash flow from operations.
CJMB Yearly Net Income VS EBIT VS OCF VS FCFCJMB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 2M -2M 4M 6M 8M

1.2 Ratios

The Return On Assets of CJMB (-52.85%) is worse than 82.61% of its industry peers.
CJMB has a worse Return On Equity (-81.34%) than 73.91% of its industry peers.
Industry RankSector Rank
ROA -52.85%
ROE -81.34%
ROIC N/A
ROA(3y)6.05%
ROA(5y)N/A
ROE(3y)-1.03%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CJMB Yearly ROA, ROE, ROICCJMB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 20 -20 40 -40 -60

1.3 Margins

CJMB has a better Gross Margin (36.31%) than 82.61% of its industry peers.
The Profit Margin and Operating Margin are not available for CJMB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CJMB Yearly Profit, Operating, Gross MarginsCJMB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40

More info and screens

7

2. Health

2.1 Basic Checks

CJMB does not have a ROIC to compare to the WACC, probably because it is not profitable.
CJMB has about the same amout of shares outstanding than it did 1 year ago.
CJMB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CJMB Yearly Shares OutstandingCJMB Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M
CJMB Yearly Total Debt VS Total AssetsCJMB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 5M 10M 15M

2.2 Solvency

CJMB has an Altman-Z score of 0.94. This is a bad value and indicates that CJMB is not financially healthy and even has some risk of bankruptcy.
CJMB has a Altman-Z score of 0.94. This is in the lower half of the industry: CJMB underperforms 69.57% of its industry peers.
CJMB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.94
ROIC/WACCN/A
WACC8.66%
CJMB Yearly LT Debt VS Equity VS FCFCJMB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 5M 10M

2.3 Liquidity

A Current Ratio of 4.26 indicates that CJMB has no problem at all paying its short term obligations.
CJMB has a better Current ratio (4.26) than 91.30% of its industry peers.
CJMB has a Quick Ratio of 4.11. This indicates that CJMB is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 4.11, CJMB belongs to the best of the industry, outperforming 91.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.26
Quick Ratio 4.11
CJMB Yearly Current Assets VS Current LiabilitesCJMB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M

More info and screens

0

3. Growth

3.1 Past

CJMB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -205.15%.
The Revenue for CJMB has decreased by -50.29% in the past year. This is quite bad
EPS 1Y (TTM)-205.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-918.18%
Revenue 1Y (TTM)-50.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-55.87%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CJMB Yearly Revenue VS EstimatesCJMB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 5M 10M 15M 20M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CJMB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CJMB Price Earnings VS Forward Price EarningsCJMB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CJMB Per share dataCJMB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CJMB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CALLAN JMB INC

NASDAQ:CJMB (12/1/2025, 1:30:01 PM)

2.6

+0.1 (+4%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryAir Freight & Logistics
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners15.81%
Inst Owner Change7.01%
Ins Owners70.81%
Ins Owner Change0%
Market Cap12.01M
Revenue(TTM)5.90M
Net Income(TTM)-4.74M
AnalystsN/A
Price TargetN/A
Short Float %0.83%
Short Ratio1.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.03
P/FCF N/A
P/OCF N/A
P/B 2.06
P/tB 2.06
EV/EBITDA N/A
EPS(TTM)-0.97
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.4
OCFYN/A
SpS1.28
BVpS1.26
TBVpS1.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -52.85%
ROE -81.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.31%
FCFM N/A
ROA(3y)6.05%
ROA(5y)N/A
ROE(3y)-1.03%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 303.18%
Cap/Sales 7.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.26
Quick Ratio 4.11
Altman-Z 0.94
F-Score2
WACC8.66%
ROIC/WACCN/A
Cap/Depr(3y)375.2%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-205.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-918.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-50.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-55.87%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-203.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-92.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-92.28%
OCF growth 3YN/A
OCF growth 5YN/A

CALLAN JMB INC / CJMB FAQ

What is the fundamental rating for CJMB stock?

ChartMill assigns a fundamental rating of 2 / 10 to CJMB.


Can you provide the valuation status for CALLAN JMB INC?

ChartMill assigns a valuation rating of 0 / 10 to CALLAN JMB INC (CJMB). This can be considered as Overvalued.


What is the profitability of CJMB stock?

CALLAN JMB INC (CJMB) has a profitability rating of 1 / 10.